HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of haemophilia patients in the COVID-19 pandemic: Experience in Wuhan and Tianjin, two differently affected cities in China.

AbstractOBJECTIVE:
To identify lessons learned from haemophilia care experience in Wuhan (COVID-19 outbreak epicenter in China) and Tianjin (with relatively low COVID-19 incidence) in the pandemic.
METHODS:
We compared the challenges in haemophilia management attributed to local COVID-19 containment policies, healthcare resource availability, clotting factors supply, daily living restrictions and coping strategies employed.
RESULTS:
Wuhan was in lockdown with strict traffic controls, enforced quarantine and overwhelmed resources. Tianjin was in relatively relaxed countermeasures to COVID-19. In Wuhan, haemophilia treatment (for bleeding, prophylaxis, multidisciplinary team care, immune tolerance induction) and patient education were severely affected, while the challenges in Tianjin were less. In both cities, patients' fear for COVID-19 infection also affected their management. Coping strategy in Wuhan included channelling of clotting factors supply from hospitals to nine pharmacies; timely transfers of in-need patients to healthcare facilities by a volunteer service network jointly coordinated by the government, hospitals and the community. Although factor concentrate supply in each city was adequate, patients still worried whether there would be enough supply to last through the pandemics. Consequently, many downgraded their treatment regimens resulting in increased bleeding episodes. In both cities, telemedicine was promoted for patient care and education.
CONCLUSIONS:
The COVID-19 pandemic had varying adverse impacts on haemophilia care depending on the local infection incidence. Our experience suggests that haemophilia management strategies in the pandemic need to be established according to the local virus containment/mitigation policies, daily living restrictions and resource availability.
AuthorsAi Zhang, Wei Liu, Man-Chiu Poon, Aiguo Liu, Xiaoping Luo, Lingling Chen, Qun Hu, Renchi Yang
JournalHaemophilia : the official journal of the World Federation of Hemophilia (Haemophilia) Vol. 26 Issue 6 Pg. 1031-1037 (Nov 2020) ISSN: 1365-2516 [Electronic] England
PMID32892465 (Publication Type: Comparative Study, Journal Article)
Copyright© 2020 John Wiley & Sons Ltd.
Topics
  • Adaptation, Psychological
  • COVID-19 (epidemiology, transmission)
  • China (epidemiology)
  • Cities
  • Containment of Biohazards
  • Health Policy
  • Health Resources
  • Health Services Accessibility
  • Hemophilia A (epidemiology)
  • Humans
  • Incidence
  • Pandemics
  • Patient Care
  • Quarantine (methods)
  • SARS-CoV-2 (physiology)
  • Telemedicine
  • Volunteers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: